Bioluminescent Cell Viability Assay via Segmented Protease Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current assays fail to accurately distinguish between live and dead cells in complex cell models, particularly in longer incubation and treatment times, as traditional viability reagents do not differentiate between cytotoxicity and cytostatic effects.

Innovation Solution

A bioluminogenic assay using a modified luciferin derivative with a protease substrate is introduced, where the dead cell population is measured first, and then live cells are lysed to subtract the dead cell signal, allowing for a single readout of both live and dead cell populations using luciferase-mediated reactions with longer half-lives.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional viability reagents are used to measure cell viability, then the number of viable cells can be determined, but the assay cannot distinguish between cytotoxicity and cytostatic effects

Engineering Contradiction:
Improvecell viability measurementVSAvoiddistinction between cytotoxicity and cytostatic effects
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The assay is divided into two sequential measurements: first measuring total cell number via ATP luminescence, then measuring dead cell number via protease activity. This segmentation allows separate quantification of viable and dead cell populations, enabling distinction between cytotoxicity (cell death) and cytostatic effects (cell cycle arrest without death).

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses protease activity as an intermediary marker for dead cells. When cells die, their membrane integrity is lost and proteases are released into the extracellular space. The protease substrate-modified luciferin serves as a mediator that detects this protease activity, providing an indirect but specific measure of dead cell population.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If cytotoxicity assays are used to detect cells that have lost membrane integrity, then the relative number of dead cells can be measured, but the remaining number of live cells cannot be determined

Engineering Contradiction:
Improvedead cell detectionVSAvoidremaining live cell count
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The assay separates the measurement of dead cells (via protease activity in the first step) from the measurement of total cells (via ATP luminescence in the second step after lysis). By segmenting the assay into these two distinct measurements, both dead cell count and live cell count can be determined from the same sample.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The dead cell measurement is performed as a preliminary action before lysing the cells. The protease substrate-modified luciferin is added first to detect dead cells, then a lysis reagent is added to release ATP from all cells for the second measurement. This preliminary measurement of dead cells enables subsequent calculation of live cell numbers.

Inventive Principle:
Principle #10Preliminary action

3Speed

If luminescence assays with short half-lives are used, then rapid detection is achieved, but the subtractive method for distinguishing live and dead cells becomes significantly complicated

Engineering Contradiction:
Improvedetection speedVSAvoidassay complexity
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The patent changes the kinetic parameter of the luminescence reaction by using substrates and conditions that produce signals with comparable half-lives. This parameter matching allows both dead cell and total cell signals to be measured within the same functional time window, enabling straightforward subtraction to determine live cell numbers without complex timing requirements.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a sensitive and accurate detection of live and dead cells, enabling precise measurement of cell viability and cytotoxicity, even in complex cell models, with the ability to detect minor differences in potency and cell number variations.

Implementation Method 1

Luminescence is produced in certain organisms as a result of a luciferase-mediated oxidation reaction

Methodology Applied
Scientific EffectLuciferase-mediated oxidation reaction: Oxidation

Implementation Method 2

Luciferase genes are widely used as genetic reporters due to the nonradioactive nature, sensitivity, and extreme linear range of luminescence assays

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Implementation Method 3

a bioluminogenic substrate for a protease... A reaction with the substrate mediated by the protease yields a product that is a substrate for luciferase

Methodology Applied
Scientific EffectProtease hydrolysis: Hydrolysis

Data Source

PatentEP2142665B1Luminescent live and dead cell assay
Publication Date: 2013.11.27 PROMEGA CORP
  • EP2142665B1 patent drawingFigure 1A~1B
  • EP2142665B1 patent drawingFigure 2A~2B
  • EP2142665B1 patent drawingFigure 3

AI summary

A method to detect live and dead cells in a sample with one bioluminogenic reagent is provided.